CervoMed receives US patent allowance for neflamapimod use in Lewy body dementia
CervoMed receives US patent allowance for neflamapimod use in Lewy body dementia
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.